Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Conditions:   Breast Cancer;   Neoadjuvant Therapy;   Neoplasm Staging;   Estrogen Receptor;   Histological Grade;   HER2;   Prognosis;   Predictive Value of Tests Intervention:   Sponsor:   Peking University First Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials